基础医学与临床 ›› 2023, Vol. 43 ›› Issue (9): 1369-1374.doi: 10.16352/j.issn.1001-6325.2023.09.1369

• 研究论文 • 上一篇    下一篇

右美托咪定通过上调PPAR-γ改善神经病理性疼痛模型大鼠的痛觉敏化

朱锋1, 钟粤1, 邓义江1, 刘文值1, 边疆2*   

  1. 1.攀枝花学院附属医院 麻醉科,四川 攀枝花 617000;
    2.攀枝花市中心医院 麻醉科,四川 攀枝花 617000
  • 收稿日期:2022-08-20 修回日期:2023-02-22 出版日期:2023-09-05 发布日期:2023-09-01
  • 通讯作者: *1105593984@qq.com
  • 基金资助:
    四川省科技厅应用基础项目(2021YJ0168)

Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ

ZHU Feng1, ZHONG Yue1, DENG Yijiang1, LIU Wenzhi1, BIAN Jiang2*   

  1. 1. Department of Anesthesiology, Affiliated Hospital of Panzhihua University, Panzhihua, 617000;
    2. Department of Anesthesiology, Panzhihua Central Hospital, Panzhihua 617000, China
  • Received:2022-08-20 Revised:2023-02-22 Online:2023-09-05 Published:2023-09-01
  • Contact: *1105593984@qq.com

摘要: 目的 探究右美托咪定(DEX)对选择性坐骨神经损伤(SNI)大鼠的镇痛作用及潜在机制。方法 将大鼠随机分为对照组,模型(SNI)组、DEX组、 DEX+GW9662组,每组12只。SNI术后1~14 d,DEX组鞘内注射右美托咪定2 μg/kg(10 μL), DEX+GW9662组鞘内注射右美托咪定2 μg/kg+PPAR-γ抑制剂(GW9662)300 μg(10 μL),对照组及SNI组仅鞘内注射相同容积的溶剂。于SNI术前1 d、术后3、7、14 d,检测大鼠的患肢足底的疼痛程度。于SNI术后14 d,用免疫荧光染色检测各组大鼠脊髓背角Iba-1的表达; Western blot检测患肢同侧脊髓背角Iba-1和PPAR-γ的表达; ELISA检测脊髓背角IFN-γ、IL-6含量。结果 SNI术后7、14 d, SNI组大鼠患肢足底疼痛程度较对照组增加,并伴有同侧脊髓背角Iba-1、PPAR-γ、IL-6、IFN-γ表达上调(P<0.05);DEX组大鼠患肢足底疼痛程度较SNI组明显减轻,并且同侧脊髓背角Iba-1、PPAR-γ、IL-6、IFN-γ的表达明显降低(P<0.05);DEX+GW9662组大鼠患肢足底疼痛程度以及脊髓背角Iba-1、PPAR-γ、IL-6、IFN-γ的表达量较DEX组均明显增加(P<0.05)。结论 右美托咪定显著改善SNI模型大鼠的痛觉敏化现象,其镇痛机制可能与上调脊髓背角PPAR-γ有关。

关键词: 右美托咪定, 神经病理性疼痛, 小胶质细胞, 过氧化酶体增殖因子-γ(PPAR-γ)

Abstract: Objective To explore the analgesic effect and underlying mechanisms of dexmedetomidine(DEX) with spared nerve injury(SNI) rat model. Methods Forty-eight SD rats were randomly divided into control group, SNI group, DEX group and DEX+GW9662 group, with 12 rats in each. From first day to 14th days after SNI surgery, rats in DEX group were intra-thecally injected with 2 μg/kg (10 μL) of dexmedetomidine,rats in DEX group were intrathecally injected with 2 μg/kg of dexmedetomidine+300 μg of PPAR-γ inhibitor (GW9662), while rats in control and SNI groups were intrathecally injected with equal volume of solvent. At day 1 before operation, day 3, 7, 14 after operation, paw withdrawal threshold and thermal withdrawal latency were detected to evaluate the painintensity. At post-operative day 14,immunofluorescence staining was used to detect the expression of Iba-1 in spinal dorsal horn, Western blot was used to detect the expression of Iba-1 and PPAR-γ in ipsilateral spinal dorsal horn, ELISA was used to detect the levels of IFN-γ and IL-6 in ipsilateral spinal dorsal horn. Results On postoperative day 7 and 14, compared with control group, the pain intensity of ipsilateral hind paw and the expression of Iba-1, PPAR-γ, IL-6 and IFN-γ in ipsilateral spinal dorsal horn were enhanced in SNI group(P<0.05). Compared with SNI group, the pain intensity of ipsilateral hind paw and the expression of Iba-1, PPAR-γ, IL-6 and IFN-γ in ipsilateral spinal dorsal horn decreased in EDX group(P<0.05). Compared with DEX group, the pain intensity of ipsilateral hind paw and the expression of Iba-1, PPAR-γ, IL-6 and IFN-γ in ipsilateral spinal dorsal increased in DEX+GW9662 group(P<0.05). Conclusions Dexmedetomidine obviously inhibits pain sensitization of SNI rats. The underlying analgesic mechanism may be related to the up-regulation of PPAR-γ in spinal dorsal horn.

Key words: dexmedetomidine, neuropathic pain, microglia, peroxisome proliferator-activated receptor-γ(PPAR-γ)

中图分类号: